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Abstract
The mechanisms behind waste clearance from deep within the parenchyma of the
brain remain unclear to this date. Experimental evidence has shown that one
pathway for waste clearance, termed intramural periarterial drainage (IPAD),
is the rapid drainage of interstitial fluid (ISF) via basement membranes (BM)
of the smooth muscle cells (SMC) of cerebral arteries and its failure is closely
associated with the pathology of Alzheimer’s disease (AD) [1, 2]. We have pre-
viously shown that arterial pulsations from the heart beat are not strong enough
to drive waste clearance [3]. Here we demonstrate computational evidence for a
mechanism for cerebral waste clearance that is driven by functional hyperaemia,
that is, the dilation of cerebral arteries as a consequence of increased neuronal
demand. This mechanism is based on our model for fluid flow through the vas-
cular basement membrane [3]. It accounts for waste clearance rates observed in
mouse experiments and aligns with pathological observations as well as recom-
mendations to lower the individual risk of AD, such as keeping mentally and
physically active.
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To this date the driving mechanisms behind waste clearance from the brain,
which lacks traditional lymphatics, remain largely unclear. However, clinical
evidence suggests a pathway for waste clearance via the basement membranes
(BM) of smooth muscle cells (SMC) within artery walls, termed intramural
periarterial drainage (IPAD). Failure of IPAD is closely associated with the
pathology of Alzheimer’s disease (AD) and has been shown to fail as a con-
sequence of a loss of the heart beat [1, 2, 4], leading to the hypothesis that
arterial pulsations due to the heart beat drive waste clearance from the brain
[5, 6, 7, 8]. However, our previous work demonstrates that arterial pulsations
are not strong enough to drive IPAD and thus the exact mechanisms behind
waste clearance from the brain remain unclear [3]. Here, using computational
simulations, we demonstrate how functional hyperaemia, which describes the di-
lation of cerebral arteries due to an increase in neuronal activitiy, may provide
the driving mechanism for cerebral waste clearance. Chemical communication
within the neurovascular unit (NVU), which comprises neurons, astrocytes and
arteries [9], can lead to a dilation of 20 % in a small artery of around 40µm
diameter [10, 11]. Combined with our model of flow through the BM [3] and a
finite element (FE) model of an artery wall we successfully demonstrate waste
clearance at a rate comparable to experimental observations [1]. Additionally
we demonstrate how this mechanism is impaired by a stiffening of the artery
wall, as commonly occurs during age and leads to risk factors for AD such as
atherosclerosis [12]. Our mechanism is in line with key pathological features of
AD and recommendations to reduce the individual risk of developing AD via
physical and mental activity by the Alzheimer’s Society [13].
The brain is the fastest metabolising organ in the body and has unique
energy demands. Whilst only taking up 2 % of our body mass it consumes
20 % of our energy [15]. Thus, adequate nutrient supply to neurons is vital in
maintaining brain function. Functional hyperaemia is the mechanism by which
the NVU increases blood flow to an active region of the brain (Figure 1). The
synapses of active neurons release glutamate (Glu) and potassium (K+), which
leads to the release of internal Ca2+ stores from the astrocyte via its endfeet.
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Figure 1: The synapses of active neurons release glutamate (Glu) and potassium (K+). K+
enters the astrocyte via Na-K pumps and inwardly rectifying K+ (KIR) channels, whilst Glu
receptors in the astrocyte lead to the production of inositol triphosphate (IP3). Internal cal-
cium (Ca2+) stores are released and lead to the production of epoxyeicosatrienoic acids (EET),
which opens big K+ (BK) channels at the astrocyte endfoot, releasing K+. KIR channels of
SMC of the artery activate and increase the extracellular K+ concentration, which closes Ca2+
channels, decreasing Ca2+ influx into the SMC and dilating the artery. The dilation activates
stretch-gated transient receptor potential channels 4 (TRPV4) on the astrocyte endfoot, lead-
ing to an influx of extracellular Ca2+ into the astrocyte [9].
Figure 2: Effect of the release of K+ and Glu into the synaptic space of a neuron and an as-
trocyte process. Glu here refers to the ratio of bound/unbound Glu receptors (dimensionless).
The arterial radius is modelled using a system of ODE [11] with corrections to the equations
listed in [14]. The model shows a dilation of the artery of 20 %.
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The SMC membrane is depolarised and the artery dilates [9]. This chemical
signalling cascade has been modelled by [11] using ordinary differential equations
(ODE), and an open source implementation of the model is found in [14]. The
dilation of an artery in response to a stimulus is shown in Figure 2 and the
displacement U(t) of the artery is defined as
U(t) = r(t)− r0, (1)
where r0 is the arterial radius at rest.
We modelled and artery wall based on an arteriole with radius r0 = 20µm as
a two-dimensional rectangle of height h = 4µm and length l = 200µm using the
FE solver FEniCS [16], using a linear elastic model with the governing equations
−∇ · σ = 0 on Ω (2)
σ = λ(∇ · u)I + µ(∇u+ (∇u)T ), (3)
where Σ describes the domain, u is the artery wall displacement, σ is the stress
tensor, I is the identity matrix and λ = 16.44 MPa and µ = 335.57 kPa are the
Lame´ coefficients. The radial boundaries were fixed in space while the longi-
tudinal boundaries were allowed to deform freely. Additionally, an astrocyte
was placed centrally on the outer longitudinal boundary, applying the Dirichlet
boundary condition
u = U(t) on ∂ΩA, (4)
where ΩA refers to a section of the outer longitudinal boundary, which models
an astrocyte. The optimal mesh consisted of 33,348 triangular elements. The
governing equations were solved for 50 s with a time step of 0.25 s, where at each
time step the boundary condition (4) was updated.
The rate of IPAD q = (q1, q2) was calculated using our model based on
Darcy’s law for porous media under thin-film flow conditions [3] in cylindrical
coordinates is governed by
q = q1ez + q2er = −K(∂p
∂z
)(
∂p
∂z
ez +
∂p
∂r
er) (5)
∂q1
∂z
+
1
r
∂
∂r
(rq2) = 0, (6)
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where ez and er describe the unit vectors in the z and r direction and K(∂p/∂z)
describes the permeability of the BM. Permeability is modelled as a step function
K(
∂p
∂z
) =
k
µ
·
K0 if ∂p/∂z < 0,K1 otherwise, (7)
where k = 1× 10−12 cm2 represents the intrinsic permeability of the extracel-
lular matrix, µ = 1.5× 10−3 Pa s represents the viscosity of ISF and the ratio
0 < K0/K1 ≤ 1.0 determines the strength of the valve [3]. Applying thin-film
flow conditions and kinematic boundary conditions the model equation
∂
∂t
(γ ·Ri(z, t) · h(z, t)) = ∂
∂z
(
Ri(z, t) · h(z, t) ·K(∂p
∂z
)
∂p
∂z
)
(8)
is derived (see [3] for details). The IPAD model requires the pressure gradient
along the artery ∂p/∂z, which can be recovered directly from the stresses inside
the artery wall, such that
p = −σrr, (9)
where σrr describes the principal component of σ in the r-direction [17].
The results are shown in Fig. 3. Displacement and stress inside the artery
wall are shown (Fig. 3a) for a single astrocyte of length 10 µm at t = 20 s,
where dilation maximal dilation of the artery has been achieved (see Fig. 2).
The stress plot shows high stresses at both ends of the artery, which are due to
the wall being fixed to u = 0. Thus, to avoid an influence of these boundary
effects on the results all further results are presented for 10 µm ≤ z ≤ 190 µm.
Experimental results from [1] suggest an expected IPAD velocity of 8µm s−1
for the mouse brain, which is adopted as a benchmark value here. Using k =
1× 10−4 µm2 and K0/K1 = 0.1 an average IPAD velocity of −8.37 µm s−1 is
achieved, where the negative sign indicates flow in the reverse direction of the
blood flow as desired (Fig. 3b). The average flow rate for the same parameters
is −7.24× 10−8 µl/min for a single arteriole (Fig. 3c). The total length of
capillaries in the brain is 400 miles [18]. Estimating the length of an average
capillary as 100µm the number of capillaries in the brain is 6.5 billion. Thus,
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Figure 3: IPAD inside a cerebral artery. (a) Displacement and stress of the artery wall
due to U(t) at t = 20 s of a single astrocyte end-foot. Because displacement is fixed to
u = 0 at the ends, stresses at the ends are high. Thus, all following results are presented for
10 µm ≤ z ≤ 190µm. (b) IPAD velocity at various time points over the length of the artery
wall using K0/K1 = 0.1. The average velocity over time and space is −8.37µm s−1. (c)
IPAD flow rate at various time points over the length of the artery wall using K0/K1 = 0.1.
The average flow rate over time and space is −7.24× 10−8 µl/min for a single arteriole.
Extrapolated over 6.5 billion arterioles estimated for the human brain it would take 9.92 h to
process the total amount of ISF in the brain (280 ml). (d) IPAD velocity for various values
of ECS permeability k over the strength of the valve mechanisms K0/K1. Values are always
negative, except for when K0/K1 = 1.0. The effect of the valve mechanism is decreased with
decreasing k.
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Figure 4: Comparison of IPAD velocities on an arteriole for varying numbers of astrocytes
acting on the wall and valve strength. An astrocyte end-foot has a width of 10 µm and the
gap between astrocytes is 1µm. Length has a negative effect on IPAD whilst the number
of astrocytes acting on the arteriole simultaneously has a positive effect. k = 1× 10−3 µm2,
arteriole length l = 309 µm, number of astrocytes: 10 (blue), 5 (orange), 2 (green), 1 (red).
it would take approximately 9.92 h to process the full volume of ISF (280 ml).
In comparison CSF has a turnover rate of three to four times a day [19].
Permeability k of the extracellular space in the brain is not known, but it
ranges between 0.01 µm2 and 1× 10−6 µm2 for interstitial spaces elsewhere in
the body [20]. Thus it is interesting to observe IPAD velocities for different
values of k and valve strength (Fig. 3d). The target velocity of ≈ 8 µm s−1 was
achieved for k = 1× 10−4 µm2, and net velocity is always negative except for
K0/K1 = 1.0, i. e. absence of a valve mechanism. A change of the permeability
by one order of magnitude results in the same change in the IPAD velocity, thus
the effect of the valve mechanism decreases with decreasing k.
Fig. 4 shows a comparison of IPAD for varying numbers of astrocytes on
a longer arteriole with l = 309 µm. Astrocyte end-feet are estimated to be
10 µm in width with 1 µm gaps in between. Increasing the arteriole length leads
to a decrease in IPAD, whilst maintaining a suitable velocity. Increasing the
number of astrocytes increases IPAD. It is interesting to note that IPAD is not
neccessarily positive at K0/K1 = 1.0, however, if it remains negative its absolute
value is more than an order of magnitude smaller compared to K0/K1 = 0.1,
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indicating stagnating flow. The dilation of the arteriole here is not caused by a
travelling wave and hence directionality of ISF flow may not be dictated by the
dilation on its own. Removing the gaps between astrocytes leads to a reduction
of IPAD, which, for ten astrocytes at K0/K1 = 0.1 reduces from −24.16 µm s−1
to −22.06 µm s−1.
Whilst our model of flow through the BM has previously disproved the well-
cited hypothesis that arterial pulsations due to the heart rate drive IPAD [3], we
have used it here to demonstrate a more realistic driving mechanism utilising the
NVU. All parameters chosen lie well within physiologically relevant ranges found
in the literature. The mechanism produces velocities in accordance with exper-
imental results from [1] and the total estimated flow rate suggests a turnover of
ISF just under three times a day, similar to the turnover rate for CSF.
Our study supports the new hypothesis that arterial dilations due to neu-
rovascular coupling may play a crucial role in waste clearance from the brain.
This hypothesis is more intuitive than the previously most cited hypothesis of
pulsations due to the heart beat driving waste clearance: Athletes have a com-
paratively low heart rate, which would put them at increased risk of developing
AD under the heart beat hypothesis. However, research shows that regular
physical activity acts as a preventive mechanism [21] and is generally beneficial
for cognitive ability [22]. It decreases amyloid load in transgenic mouse mod-
els [23] and reduces the risk of hippocampal atrophy in individuals at genetic
risk of developing AD [24]. Our neurovascular coupling hypothesis supports
and can explain these findings. Physical activity leads to increased neuronal
activity, which demands better nutrient supply and, according to our model, is
accompanied by increased IPAD and thus decreased amyloid load. Analogously,
the same recommendation applies more generally for any cognitively engaging
type of activity [25, 26, 27] and is equally well explained by our hypothesis
and supported by our model. In addition our hypothesis supports the findings
that cardiovascular diseases such as atherosclerosis and hypertension pose risk
factors for AD [12], most likely via two mechanisms: a decresed response to
the astrocyte due to a stiffening of the artery wall and stagnating IPAD due
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to a dysfunction of the valve mechanism. We conclude that our neurovascular
hypothesis of the mechanism behind IPAD offers suitable explanations for car-
diovascular findings associated with AD and should thus act as the new working
hypothesis for the mechanism behind IPAD.
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